Good luck to all. I note that there are several ARTH cheerleaders on this board, continuing to find land in an empty hat. Since I am now done here, I will only say that investors should stick to the facts. ARTH has scrupulously avoided providing any meaningful facts, which by itself should be very worrisome to objective observers. Another clue is the high executive & directors comp, especially in relation to R&D expenditures. Some people have tried to constuct a positive story. In the end, facts will tell the story.
News 
Market Data 
Discover 
